
Arkus AI Tool’s User Study Project is approved to be a Nationwide Test in Sweden
We are proud to share that we have been granted ethical approval to extend our Arkus AI Tool’s user study project nationwide.
Read more
We are proud to share that we have been granted ethical approval to extend our Arkus AI Tool’s user study project nationwide.
Read more
We’re proud to announce a new collaboration with Örebro University Hospital! Our AI-powered tool will support the streamlining and digitalisation of the genetic investigation workflow.
Read more
We are thrilled to announce our first customer, the renowned Karolinska University Hospital, following the successful completion of a joint pilot study. We are honoured to enter a software licensing agreement that our AI tool is used by medical staff at the hereditary cancer clinic to enhance workflow efficiency and quality. By streamlining and digitising \[…\]
Read more
On September 18th, Arkus AI had the distinct honor of being invited by the Swedish Parliament’s Social and Healthcare Working Group to present our AI application in hereditary cancer and precision medicine. During the session, our leadership team (CEO Ying Cheng, CTO Vladimir Li and Head of Software Mathias Fernström) engaged in deep, insightful discussions \[…\]
Read more
We are thrilled to congratulate Svetlana Bajalica Lagercrantz, our esteemed Expert Advisor in Oncogenetics, for being awarded the Process Manager of the Year 2024 by RCC Stockholm Gotland! Svetlana’s tireless dedication and pioneering work in Personalised Cancer Prevention have significantly advanced the field of hereditary cancer care. Her efforts to enhance genetic knowledge and improve \[…\]
Read more
Arkus AI is proud to announce our recent participation in ‘Företagarnas Dagar,’ a highly esteemed event organized by Svenskt Näringsliv. This gathering brought together over 300 industry leaders and nearly 100 members of parliament, making it a monumental occasion for networking and collaboration. During the event, our CEO Ying Cheng and CTO Vladimir Li were \[…\]
Read more
We are pleased to announce a significant development in our collaboration with Karolinska Hospital on the project “User Studies for a Digital Tool for Genetic Counselling (Användarstudier av tillämpning av digitala verktyg i den genetisk vägledarprocessen inom hälso- och sjukvård)”. This project has received ethical approval, marking a key step in our shared effort to \[…\]
Read more






Arkus Al’s founder Dr. Ying Cheng met with Dr. Magnus Burstedt, the Head of Medicine, and his colleagues, and had very constructive discussions. Together, we performed UX analysis surrounding some of the genetic diagnostic analysis work. We believe it is crucial to involve customers and users earlier in the product development of Al-powered genetic diagnostic \[…\]
Read more
We are excited and honored to receive the Startup Grant from Vinnova!
Read more
Arkus Al are excited to announce our latest partnership with Medicover Genetics Gmbh to innovate and apply AI (Artificial Intelligence) in the field of genetic diagnostics. Medicover Genetics Gmbh is part of Medicover Group, a forward-looking international leader in the healthcare and diagnostic service industries. Armed with Medicover’s world-leading clinical genetics expertise and deep understanding \[…\]
Read more